Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
CGRP-remmers bij chronische migraine onder voorwaarden in basispakket
sep 2021 | Hoofdpijn